XK aprosencephaly syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:3469OMIM:207770Q04.3
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

XK aprosencephaly syndrome, also known as XK aprosencephaly-situs abnormality syndrome, is an extremely rare and lethal congenital malformation syndrome characterized by a severe brain defect called aprosencephaly, which represents the most extreme form of prosencephalic developmental failure. In aprosencephaly, the forebrain (prosencephalon) fails to develop, resulting in an absence of cerebral hemispheres and related structures. This condition is even more severe than alobar holoprosencephaly. Affected individuals present with profound craniofacial anomalies including absence of recognizable facial features (aprosopia or severe facial dysmorphism), absence or severe malformation of the eyes, nose, and mouth structures, and microcephaly. Additional features may include situs abnormalities (abnormal positioning of internal organs), limb defects, and other visceral malformations. The condition is incompatible with life, and affected infants are typically stillborn or die shortly after birth. The syndrome was described in siblings, suggesting an autosomal recessive inheritance pattern. The exact genetic cause has not been fully elucidated. Given the lethal nature of this condition, there is no curative treatment. Management, when applicable, is limited to supportive and palliative care. Genetic counseling is recommended for affected families to assess recurrence risk in future pregnancies.

Also known as:

Clinical phenotype terms— hover any for plain English:

Abnormality of the pharynxHP:0000600Abnormal external genitalia morphologyHP:0000811Abnormal morphology of the radiusHP:0002818Abnormal nostril morphologyHP:0005288
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for XK aprosencephaly syndrome.

View clinical trials →

No actively recruiting trials found for XK aprosencephaly syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the XK aprosencephaly syndrome community →

No specialists are currently listed for XK aprosencephaly syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to XK aprosencephaly syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open XK aprosencephaly syndromeForum →

No community posts yet. Be the first to share your experience with XK aprosencephaly syndrome.

Start the conversation →

Latest news about XK aprosencephaly syndrome

No recent news articles for XK aprosencephaly syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about XK aprosencephaly syndrome

What is XK aprosencephaly syndrome?

XK aprosencephaly syndrome, also known as XK aprosencephaly-situs abnormality syndrome, is an extremely rare and lethal congenital malformation syndrome characterized by a severe brain defect called aprosencephaly, which represents the most extreme form of prosencephalic developmental failure. In aprosencephaly, the forebrain (prosencephalon) fails to develop, resulting in an absence of cerebral hemispheres and related structures. This condition is even more severe than alobar holoprosencephaly. Affected individuals present with profound craniofacial anomalies including absence of recognizabl

How is XK aprosencephaly syndrome inherited?

XK aprosencephaly syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does XK aprosencephaly syndrome typically begin?

Typical onset of XK aprosencephaly syndrome is neonatal. Age of onset can vary across affected individuals.